CASI製藥 | SC 13D/A:超過5%持股股東披露文件(修正)-WEI-WU HE, Ph.D.(20.94%),EMERGING TECHNOLOGY PARTNERS, LLC(7.1%)等
CASI製藥 | SC 13G:超過5%持股股東披露文件-Venrock Healthcare Capital Partners III, L.P.(9.99%),VHCP Co-Investment Holdings III, LLC(9.99%)等
CASI製藥 | D:發行公告
CASI製藥 | SC 13G:超過5%持股股東披露文件-Foresite Capital Fund VI, L.P. (“FCF VI”)(9.8%),Foresite Capital Management VI, LLC (“FCM VI”)(9.8%)等
CASI製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-James Huang(8.4%),Panacea Venture Healthcare Fund II, L.P.(7.6%)等
CASI製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-James Huang(19.99%),Panacea Venture Healthcare Fund II, L.P.(19.31%)等
CASI製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-James Huang(18.0%),Panacea Venture Healthcare Fund II, L.P.(17.4%)等
CASI製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-James Huang(13.0%),Panacea Venture Healthcare Fund II, L.P.(12.3%)等
CASI製藥 | SC 13D/A:超過5%持股股東披露文件(修正)
CASI製藥 | SC 13G:超過5%持股股東披露文件-Panacea Venture Healthcare Fund II, L.P.(9.2%),Panacea Venture Healthcare Fund II GP Company, Ltd.(9.2%)等
CASI製藥 | SC 13D/A:超過5%持股股東披露文件(修正)-Quan Zhou(7.7%),IDG-Accel China Growth Fund III L.P.(7.2%)等
CASI製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-Federated Hermes, Inc.(4.86%),Voting Shares Irrevocable Trust(4.86%)等
CASI製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-Federated Hermes, Inc.(6.62%),Voting Shares Irrevocable Trust(6.62%)等
CASI製藥 | 4:持股變動聲明
CASI製藥 | 4:持股變動聲明
CASI製藥 | 4:持股變動聲明
CASI製藥 | 4:持股變動聲明
CASI製藥 | 4:持股變動聲明
CASI製藥 | SC 13D/A:超過5%持股股東披露文件(修正)-WEI-WU HE, Ph.D.(18.95%),EMERGING TECHNOLOGY PARTNERS, LLC(8.89%)等
CASI製藥 | 4:持股變動聲明
暫無數據
暫無數據